These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Prevention of tilorone developmental toxicity with progesterone. Terry RD, Marks TA, Hamilton RD, Pitts TW, Renis HE. Teratology; 1992 Sep; 46(3):237-50. PubMed ID: 1523581 [Abstract] [Full Text] [Related]
6. Prevention of human recombinant interleukin-1 beta (rhIL-1 beta) embryolethality with progesterone or indomethacin. Marks TA, Tracy DE. Am J Reprod Immunol; 1995 Apr; 33(4):292-300. PubMed ID: 7546248 [Abstract] [Full Text] [Related]
9. Protection from carcinogen-induced murine bladder carcinoma by interferons and an oral interferon-inducing pyrimidinone, bropirimine. Borden EC, Sidky YA, Ertürk E, Wierenga W, Bryan GT. Cancer Res; 1990 Feb 15; 50(4):1071-4. PubMed ID: 2297754 [Abstract] [Full Text] [Related]
20. The role of maternal toxicity in lovastatin-induced developmental toxicity. Lankas GR, Cukierski MA, Wise LD. Birth Defects Res B Dev Reprod Toxicol; 2004 Jun 15; 71(3):111-23. PubMed ID: 15282732 [Abstract] [Full Text] [Related] Page: [Next] [New Search]